Announcements Trials
Browse Landscape

Phase

Phase 1 13Phase NA 6Phase 1/2 2

Status

Completed 6Terminated 4Unknown 2Recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 72Breast Neoplasms 63Neoplasms 59Leukemia, Myeloid, Acute 58Multiple Myeloma 52Colorectal Neoplasms 48Lymphoma 46Stomach Neoplasms 43Recurrence 43Carcinoma, Hepatocellular 43Pancreatic Neoplasms 40Neoplasm Metastasis 39Melanoma 34Prostatic Neoplasms 33Leukemia 30Lymphoma, Non-Hodgkin 27Lymphoma, B-Cell 27Lung Neoplasms 27Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Glioblastoma 24Ovarian Neoplasms 23Lymphoma, Large B-Cell, Diffuse 21Esophageal Neoplasms 21Carcinoma, Renal Cell 20Myelodysplastic Syndromes 19Leukemia, Lymphocytic, Chronic, B-Cell 19Hematologic Neoplasms 19Colonic Neoplasms 19Head and Neck Neoplasms 18Lymphoma, Mantle-Cell 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Unknown × Advanced Cancer × Clear all
NCT04376931 2020-07-29

A Prospective Dose Finding Study of Iscador Infusion

HaEmek Medical Center, Israel

Phase 1/2 Unknown
24 enrolled

Advanced Cancer

NCT04124666 2019-12-19

Clinical Study of Granulocyte Infusion for Advanced Cancer

Shanghai East Hospital

Phase 1/2 Unknown
100 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡